{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"tesamorelin-nerve-damage","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tesamorelin-nerve-damage/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"tesamorelin-nerve-damage","title":"Tesamorelin for Nerve Damage: Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:24.259Z","body_excerpt":"## What's breaking down\nNerve damage often involves axonal disruption after injury, followed by slow or incomplete regeneration. Denervated muscle can atrophy over time because it receives no signals to maintain mass and strength. Repair pathways rely on growth factors and hormones that support axon regrowth and prevent wasting. When these signals stay low, functional recovery stalls even after surgical repair. Degeneration outpaces repair in many cases, leaving persistent sensory loss, weakness, or pain. Tesamorelin fits into discussions of the GH axis because it raises growth hormone levels, and GH has been linked in lab models to better axon regrowth and less muscle loss.\n\n## Why Tesamorelin might help you\n1. If your nerve injury leaves muscle without signals, GH elevation is discussed because animal work shows it can limit atrophy during the wait for reinnervation. 2. If axonal regrowth is the bottleneck, the same GH pathway is studied because it appears to support faster axon extension and better myelin thickness in rat models. 3. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. It raises GH via the GHRH receptor, which in turn influences downstream factors tied to nerve and muscle maintenance.\n\n## How these fit together\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. Tesamorelin targets the GH axis and its potential effects on visceral fat reduction alongside tissue repair signals. No other peptides are in scope here, so the discussion stays on how GH stimulation might intersect with nerve regeneration layers without overlapping essays on separate compounds.\n\n## What the evidence actually shows\nHuman data: One ongoing randomized, double-blinded, placebo-controlled Phase 2 trial (NCT03150511) tests tesamorelin after upper-extremity nerve repair. It started in 2018, remains recruiting as of late 2025, and has an estimated primary completion in 2027. No published results exist yet. The trial rationale rests on prior animal findings that GH improves nerve regeneration and functional recovery. Preclinical data: A 2019 rat study used systemic GH after chronic median-nerve denervation followed by nerve transfer. GH-treated rats showed higher axon density, larger axon diameter, thicker myelin, more reinnervated neuromuscular junctions, less muscle atrophy, and stronger grip recovery compared with untreated controls (preclinical tier). No completed human trials demonstrate tesamorelin efficacy for nerve damage. Approved human use of tesamorelin centers on visceral fat reduction in HIV patients, with secondary observations of muscle area and density changes in responders (human tier for that indication).\n\n## What scientists say\nResearchers at Johns Hopkins running the ongoing trial note that growth hormone has improved nerve regeneration and reduced muscle atrophy in animal models, forming the basis for testing tesamorelin in patients. They hypothesize faster motor and sensory recovery after surgical repair. Published reviews on peripheral nerve injury mention the trial as an example of growth-hormone-pathway exploration but do not cite outcome data because none are available.\n\n## What people say on Reddit\nAnecdotal reports mention hopes for post-surgical nerve growth but no clear personal confirmation of benefit after a cycle. Several users describe fluid-retention effects such as wrist aching, tingling, or carpal-tunnel-like symptoms while on tesamorelin; one linked these to elevated GH and resolved after stopping. Another reported reactive hypoglycemia requiring ER care shortly after starting. These are user experiences only and do not establish cause or efficacy for nerve repair.\n\n## What people say on X\nLimited public discussion appears on X specifically tying tesamorelin to nerve-damage outcomes. Searches surface general peptide conve","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"An ongoing Phase 2 randomized double-blinded placebo-controlled trial (NCT03150511) is testing tesamorelin for functional recovery after peripheral nerve injury, with estimated completion in 2027 and no results published as of late 2025.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes current state of human evidence for the exact use case.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"Tesamorelin is approved for visceral fat reduction in HIV patients and has shown increases in skeletal muscle area and density in treatment responders in secondary analyses of those trials.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Documents established human data on GH-axis effects.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"In a 2019 rat study, systemic GH after chronic denervation and nerve transfer improved axon density, diameter, myelin thickness, neuromuscular junction reinnervation, reduced muscle atrophy, and grip strength recovery compared with controls.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Provides the animal data cited as rationale for human testing.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"Reddit users report fluid-retention side effects including wrist pain, tingling, and in one case reactive hypoglycemia while using tesamorelin; one user hoped for post-surgery nerve growth but observed no clear benefit.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4","s5"],"source_status":"sourced","why_material":"Captures user-reported experiences separate from trials.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT03150511","title":"Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury","quote":"The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. ... Recruiting ... Last Update Posted 2025-11-12 ... Primary Completion (Estimated) 2027-12","summary":"Ongoing Phase 2 trial details and status.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"c92fc5e450195b0494841a44ff38c7d3ef5ba07383cd288e70c209d50ef4a49c"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6395714/","title":"Growth Hormone Improves Nerve Regeneration, Muscle Re-Innervation, and Functional Outcomes After Chronic Denervation Injury","quote":"GH-treated animals demonstrated enhanced median nerve regeneration as measured by axon density (p < 0.005), axon diameter (p < 0.0001), and myelin thickness (p < 0.0001); improved muscle re-innervation ... reduced muscle atrophy ... greater recovery of motor function","summary":"2019 rat study on GH for nerve regeneration.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"46181b5b77988cd160f119bfdcb23367a43e773ed9529e13995640ac3c6999ac"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin Decreases Visceral Adipose Tissue...","quote":"Tesamorelin was associated with significantly greater increases in density of four truncal muscle groups ... and the lean ... muscles ... Significant increases were also seen in total area of the rectus and psoas muscles","summary":"Human data on muscle effects in HIV patients.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"14d3cb51f640124eb7184cf6521e90bb9e8b3e452a100e2566fd67f8c1f4f600"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1e4ai7g/tesamorelin_no_recomp_occurring/","title":"Tesamorelin - no recomp occurring","quote":"My primary goal was to see if I got any nerve growth 1-2 yrs post surgery, but I'm at the end of the cycle and there's just no way to tell","summary":"User anecdote on hoped-for nerve benefit.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"254137c5bf9064c4092f297117134a000381e9248fd879a75d36b095d6939197"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1pjk16m/tesamorelin_possibly_sent_me_to_the_er/","title":"Tesamorelin possibly sent me to the ER","quote":"I became extremely dizzy, anxious, shaky ... blood sugar ... below 40 ... diagnosed with reactive hypoglycemia","summary":"User report of side effect.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"7f4ca453e9421329c6c872f48863b97e6ccaeab65922672b0acf00c0085ab054"}],"anecdotal_sources":[{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1e4ai7g/tesamorelin_no_recomp_occurring/","title":"Tesamorelin - no recomp occurring","quote":"My primary goal was to see if I got any nerve growth 1-2 yrs post surgery, but I'm at the end of the cycle and there's just no way to tell","summary":"User anecdote on hoped-for nerve benefit.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"254137c5bf9064c4092f297117134a000381e9248fd879a75d36b095d6939197"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Biohackers/comments/1pjk16m/tesamorelin_possibly_sent_me_to_the_er/","title":"Tesamorelin possibly sent me to the ER","quote":"I became extremely dizzy, anxious, shaky ... blood sugar ... below 40 ... diagnosed with reactive hypoglycemia","summary":"User report of side effect.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"7f4ca453e9421329c6c872f48863b97e6ccaeab65922672b0acf00c0085ab054"}],"scientific_sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT03150511","title":"Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury","quote":"The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. ... Recruiting ... Last Update Posted 2025-11-12 ... Primary Completion (Estimated) 2027-12","summary":"Ongoing Phase 2 trial details and status.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"c92fc5e450195b0494841a44ff38c7d3ef5ba07383cd288e70c209d50ef4a49c"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6395714/","title":"Growth Hormone Improves Nerve Regeneration, Muscle Re-Innervation, and Functional Outcomes After Chronic Denervation Injury","quote":"GH-treated animals demonstrated enhanced median nerve regeneration as measured by axon density (p < 0.005), axon diameter (p < 0.0001), and myelin thickness (p < 0.0001); improved muscle re-innervation ... reduced muscle atrophy ... greater recovery of motor function","summary":"2019 rat study on GH for nerve regeneration.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"46181b5b77988cd160f119bfdcb23367a43e773ed9529e13995640ac3c6999ac"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6766405/","title":"The Growth Hormone Releasing Hormone Analogue Tesamorelin Decreases Visceral Adipose Tissue...","quote":"Tesamorelin was associated with significantly greater increases in density of four truncal muscle groups ... and the lean ... muscles ... Significant increases were also seen in total area of the rectus and psoas muscles","summary":"Human data on muscle effects in HIV patients.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"14d3cb51f640124eb7184cf6521e90bb9e8b3e452a100e2566fd67f8c1f4f600"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"tesamorelin-nerve-damage","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":5,"anecdotal":2,"scientific":3,"user_reports":0,"questions":0,"evidence_ingests":0}}